In the global arena of biomedicine, Guangzhou's innovative drug companies are rewriting the rules with "hard‑core technology.

Current written description jurisprudence can make it difficult to obtain broad antibody patents, leading practitioners to explore ...

In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...

Antibody molecules, or “immunoglobulins”, have been recognized only in vertebrates and all are found to have a fundamentally similar structure consisting of two heavy and two light peptide chains.

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

Q3 2025 Earnings Call Transcript March 28, 2025 ImmunoPrecise Antibodies Ltd. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. Operator: Good morning, ...

Having picked up a pipeline of oncology drugs as part of a merger last year, NAYA Biosciences is reverting back to its ...

FDA introduces a new roadmap to reduce animal testing in monoclonal antibody development using AI models, organoid testing and real-world data to enhance safety and efficiency.

Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or ...

Like puzzle pieces, these components fit together to form a stable structure capable of tightly binding to pathogenic proteins. This innovative design mimics the precise and powerful function of ...